Company: Dr. Reddy's Laboratories Ltd. Category: Independent Research


Shares of the drugmaker have gained 38 percent in the past 12 months, beating peers.
May 10, 2019, 10:31 a.m.

U.S. government shutdown may hit Dr. Reddy’s plans to enter its largest market for generics of Suboxone.
Jan. 30, 2019, 10:25 a.m.

Dr Reddy’s Laboratories US FDA Inspection of Miryalaguda – Form 483 Revealed | Capitalmind
Sept. 12, 2017, 11:56 a.m.
Publisher: capitalmind.in

Today we cover the Form 483 [What is a Form 483?] issued by the US FDA [United States Food and Drug Administration] to Dr. Reddy’s oncology formulation [Duvvuda unit makes cytotoxic and hormonal injectables] manufacturing facility at Duvvada at Visakhapatnam, Andhra Pradesh.
Sept. 11, 2017, 1:08 p.m.
Publisher: capitalmind.in

  • 1
-->